GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunic Inc (NAS:IMUX) » Definitions » E10

Immunic (Immunic) E10 : $-45.46 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Immunic E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Immunic's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.480. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-45.46 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-01), Immunic's current stock price is $1.30. Immunic's E10 for the quarter that ended in Dec. 2023 was $-45.46. Immunic's Shiller PE Ratio of today is .


Immunic E10 Historical Data

The historical data trend for Immunic's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunic E10 Chart

Immunic Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -64.57 -63.65 -45.46

Immunic Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.65 -59.44 -56.34 -52.14 -45.46

Competitive Comparison of Immunic's E10

For the Biotechnology subindustry, Immunic's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunic's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunic's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Immunic's Shiller PE Ratio falls into.



Immunic E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Immunic's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.48/129.4194*129.4194
=-0.480

Current CPI (Dec. 2023) = 129.4194.

Immunic Quarterly Data

per share eps CPI Adj_EPS
201403 -26.176 99.695 -33.981
201406 -36.400 100.560 -46.847
201409 -23.600 100.428 -30.413
201412 -23.600 99.070 -30.830
201503 -24.800 99.621 -32.218
201506 -25.200 100.684 -32.392
201509 -20.400 100.392 -26.299
201512 -13.600 99.792 -17.638
201603 -12.400 100.470 -15.973
201606 -12.000 101.688 -15.273
201609 -12.800 101.861 -16.263
201612 -14.800 101.863 -18.804
201703 -15.600 102.862 -19.628
201706 -11.600 103.349 -14.526
201709 -12.000 104.136 -14.914
201712 -14.000 104.011 -17.420
201803 -13.600 105.290 -16.717
201806 -12.000 106.317 -14.608
201809 -11.200 106.507 -13.609
201812 -2.400 105.998 -2.930
201903 -5.090 107.251 -6.142
201906 -1.520 108.070 -1.820
201909 -0.820 108.329 -0.980
201912 -0.560 108.420 -0.668
202003 -0.790 108.902 -0.939
202006 -0.900 108.767 -1.071
202009 -0.700 109.815 -0.825
202012 -0.460 109.897 -0.542
202103 -1.630 111.754 -1.888
202106 -0.820 114.631 -0.926
202109 -0.760 115.734 -0.850
202112 -0.600 117.630 -0.660
202203 -0.740 121.301 -0.790
202206 -0.720 125.017 -0.745
202209 -0.690 125.227 -0.713
202212 -1.620 125.222 -1.674
202303 -0.580 127.348 -0.589
202306 -0.540 128.729 -0.543
202309 -0.510 129.860 -0.508
202312 -0.480 129.419 -0.480

Add all the adjusted EPS together and divide 10 will get our e10.


Immunic  (NAS:IMUX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Immunic E10 Related Terms

Thank you for viewing the detailed overview of Immunic's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunic (Immunic) Business Description

Traded in Other Exchanges
Address
1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Executives
Glenn Whaley officer: PAO and Controller C/O PERNIX THERAPEUTICS HOLDINGS, INC., 10 NORTH PARK PLACE, SUITE 201, MORRISTOWN NJ 07960
Richard Alan Rudick director 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK NY 10036
Joerg Neermann director IMMUNIC AG, AM KLOPFERSPITZ 19, MARTINSRIED 2M 82152
Daniel Vitt director, officer: CEO, President IMMUNIC AG, AM KLOPFERSPITZ 19, MARTINSRIED 2M 82152
Monika Maria Toernsen director ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA PA 19103
Duane Nash director C/O VITAL THERAPIES, INC., 15010 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128
Andreas Muehler officer: Chief Medical Officer 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK CITY NY 10036
Manfred Groeppel officer: Chief Operating Officer IMMUNIC AG, AM KLOPFERSPITZ 19, MARTINSRIED 2M 82152
Barclay A Phillips director C/O CANCER VAX CORP, 2110 RUTHERFORD ROAD, CARLSBAD CA 92008
Tamar D Howson director
Sanjay S Patel officer: Chief Financial Officer 10 N. PARK PLACE, SUITE 201, MORRISTOWN NJ 07960
Claudio Nessi 10 percent owner C/O NEOMED, 7 PLACE DU MOLARD, 1204 GENEVA V8 1204
Anne-mari Paster 10 percent owner C/O OMEGA FUND MANAGEMENT, LLC, 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Omega Fund V Gp, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Lsp V Cooperatieve U.a. 10 percent owner JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV

Immunic (Immunic) Headlines

From GuruFocus

Is Immunic Inc Undervalued Following the Latest Insider Buy?

By GuruFocus Research GuruFocus Editor 05-18-2023